机构:[1]AMI Key Laboratory of Chinese Medicine in Guangzhou, Guangdong Province Hospital of Chinese Medicine, the 2nd Affi liated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Science, Guangzhou (510006), China广东省中医院[2]Intensive Care Research Team of Traditional Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, the 2nd Affi liated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Science, Guangzhou (510006), China广东省中医院[3]Animal Laboratory, Guangdong Province Hospital of Chinese Medicine, Guangzhou (510006), China广东省中医院
Objective To study the protective mechanism of Chinese medicine Suxiao Jiuxin Pills (& x901f;(sic)& x6551;(sic)& x4e38;, SXJ) on myocardial ischemia and reperfusion (I/R) injury. Methods Mouse myocardial I/R injury model was created by 30-min coronary artery occlusion followed by 24-h reperfusion, the mice were then divided into the sham group (n=7), the I/R group (n=13), the tirofiban group (TIR, positive drug treatment,n=9), and the SXJ group (n=11). Infarct size (IS), risk region (RR), and left ventricle (LV) were analyzed with double staining methods. In addition, H9C2 rat cardiomyocytes were cultured with Na(2)S(2)O(4)to simulate I/Rin vitro. The phosphorylation of extracellular regulated protein kinases1/2 (ERK1/2), protein kinase B (AKT), glycogen synthase kinase-3 beta (GSK3 beta), and protein expression of GATA4 in nucleus were detected with Western blot assay. Results The ratio of IS/RR in SXJ and TIR groups were lower than that in I/R group (SXJ, 22.4% +/- 6.6%; TIR, 20.8%+/- 3.3%; vs. I/R, 35.4%+/- 3.7%,P<0.05, respectively).In vitroexperiments showed that SXJ increased the Na2S2O4-enhanced phosphorylation of AKT/GSK3 beta and nuclear expression of GATA4. Conclusion SXJ prevents myocardial I/R injury in mice by activating AKT/GSK3 beta and GATA4 signaling pathways.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81473471, 81603429]; Foundation of Guangdong Hospital of Chinese Medicine [YK2013B2N11, YN2014ZH01, YN2014ZHR203, YN2016QJ19]
第一作者机构:[1]AMI Key Laboratory of Chinese Medicine in Guangzhou, Guangdong Province Hospital of Chinese Medicine, the 2nd Affi liated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Science, Guangzhou (510006), China[2]Intensive Care Research Team of Traditional Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, the 2nd Affi liated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Science, Guangzhou (510006), China
通讯作者:
通讯机构:[1]AMI Key Laboratory of Chinese Medicine in Guangzhou, Guangdong Province Hospital of Chinese Medicine, the 2nd Affi liated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Science, Guangzhou (510006), China[2]Intensive Care Research Team of Traditional Chinese Medicine, Guangdong Province Hospital of Chinese Medicine, the 2nd Affi liated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Science, Guangzhou (510006), China
推荐引用方式(GB/T 7714):
Tan Ya-fang,Yu Juan,Pan Wen-jun,et al.Protective Mechanisms of Suxiao Jiuxin Pills (速效救心丸) on Myocardial Ischemia-Reperfusion Injury in vivo and in vitro[J].CHINESE JOURNAL OF INTEGRATIVE MEDICINE.2020,26(8):583-590.doi:10.1007/s11655-020-2726-2.
APA:
Tan, Ya-fang,Yu, Juan,Pan, Wen-jun,Qi, Jian-yong&Zhang, Min-zhou.(2020).Protective Mechanisms of Suxiao Jiuxin Pills (速效救心丸) on Myocardial Ischemia-Reperfusion Injury in vivo and in vitro.CHINESE JOURNAL OF INTEGRATIVE MEDICINE,26,(8)
MLA:
Tan, Ya-fang,et al."Protective Mechanisms of Suxiao Jiuxin Pills (速效救心丸) on Myocardial Ischemia-Reperfusion Injury in vivo and in vitro".CHINESE JOURNAL OF INTEGRATIVE MEDICINE 26..8(2020):583-590